Science Explorer Back to mapMap

Most cited papers from Cellerant Therapeutics (United States)

What are the most cited papers from Cellerant Therapeutics (United States)?

The most cited paper from Cellerant Therapeutics (United States) is "Targeting renal cell carcinoma with a HIF-2 antagonist" (Wenfang Chen et al., 2016), with 744 citations. Next come "On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models" (469) and "Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development" (324).

Showing 44 of 44 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Targeting renal cell carcinoma with a HIF-2 antagonist Wenfang Chen et al. · Nature Open access 5 Sep 2016 744
2 On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models Hyejin Cho, Xinlin Du, James P. Rizzi et al. · Nature Open access 5 Sep 2016 469
3 Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development Matthew A. Inlay, Deepta Bhattacharya, Debashis Sahoo et al. · Genes & Development Open access 15 Oct 2009 324
4 Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors Baharak Bahmani, Hua Gong, Brian T. Luk et al. · Nature Communications Open access 31 Mar 2021 303
5 Identification of the earliest natural killer cell–committed progenitor in murine bone marrow John W. Fathman, Deepta Bhattacharya, Matthew A. Inlay et al. · Blood Open access 20 Sep 2011 214
6 CLT030, a leukemic stem cell–targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia Ying-Ping Jiang, Bob Y. Liu, Quan Zheng et al. · Blood Advances Open access 23 Jul 2018 72
7 Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells Stephanie Smith‐Berdan, Daphne Gille, Irving L. Weissman et al. · Blood Open access 14 Apr 2007 67
8 Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2Akita mouse Sally L. Elshaer, William Edward Evans, Mickey Pentecost et al. · Stem Cell Research & Therapy Open access 21 Nov 2018 62
9 Myeloid Progenitors: A Radiation Countermeasure that is Effective when Initiated Days after Irradiation Vijay Kumar Singh, Julie Anja Engelhard Christensen, Oluseyi O. Fatanmi et al. · Radiation Research Jun 2012 62
10 Concentrated Conditioned Media from Adipose Tissue Derived Mesenchymal Stem Cells Mitigates Visual Deficits and Retinal Inflammation Following Mild Traumatic Brain Injury Kumar Abhiram Jha, Mickey Pentecost, Raji Rajesh Lenin et al. · International Journal of Molecular Sciences Open access 11 Jul 2018 61
11 Self-Renewal of the Long-Term Reconstituting Subset of Hematopoietic Stem Cells Is Regulated by Ikaros Peter Papathanasiou, Joanne L. Attema, Holger Karsunky et al. · Stem Cells Open access 8 Oct 2009 45
12 Fatty Acid Transport Protein 4 (FATP4) Prevents Light-Induced Degeneration of Cone and Rod Photoreceptors by Inhibiting RPE65 Isomerase Songhua Li, Jungsoo Lee, Yongdong Zhou et al. · Journal of Neuroscience Open access 13 Feb 2013 36
13 FLT3 Inhibitor Maintenance After Allogeneic Transplantation: Is a Placebo-Controlled, Randomized Trial Ethical? Mark J. Levis, Yi‐Bin Chen, Mehdi Hamadani et al. · Journal of Clinical Oncology Open access 29 Apr 2019 31
14 Incorporating Digital Dentures into Clinical Practice: Flexible Workflows and Improved Clinical Outcomes Pamela Maragliano‐Muniz, Eric D. Kukucka · Journal of Prosthodontics 31 Oct 2020 26
15 Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia Pinkal M. Desai et al. · Journal of Clinical Oncology Open access 22 Jun 2021 21
16 Design and Synthesis of Isoquinolidinobenzodiazepine Dimers, a Novel Class of Antibody–Drug Conjugate Payload Sean Weston Smith, Vasu Jammalamadaka, Dmitry Borkin et al. · ACS Medicinal Chemistry Letters Open access 6 Dec 2017 14
17 A first-in-human phase I/II trial of the oral HIF-2a inhibitor PT2977 in patients with advanced RCC Eric W. Jonasch, Elizabeth R. Plimack, Todd Michael Bauer et al. · Annals of Oncology Open access Oct 2019 13
18 Surface‐Functionalized Carrier‐Free Drug Nanorods for Leukemia Vinu Krishnan, Apoorva Sarode, Rohit Bhatt et al. · Advanced Therapeutics 16 May 2018 12
19 Hepatic parenchymal replacement in mice by transplanted allogeneic hepatocytes is facilitated by bone marrow transplantation and mediated by CD4 cells Konrad L. Streetz, Régis Doyonnas, Dirk Grimm et al. · Hepatology Open access 26 Jan 2008 12
20 Renal failure causes early death of bcl-2 deficient mice Lev M. Fedorov, Carolin Schmittwolf, Kerstin Amann et al. · Mechanisms of Ageing and Development 19 Apr 2006 12
21 Biomaterials for tissue engineering and regenerative medicine: Treatment of musculoskeletal injury and disease Kanika Chawla · Materials Science and Engineering A 30 Jun 2012 10
22 In vitro characterization of CT‐001—a short‐acting factor VIIa with enhanced prohemostatic activity Derek Sim, Cornell R. Mallari, John M. Teare et al. · Research and Practice in Thrombosis and Haemostasis Open access Jul 2021 7
23 Maintenance of Multipotency in Human Dermal Fibroblasts Treated with Xenopus laevis Egg Extract Requires Exogenous Fibroblast Growth Factor-2 Denis Kole, Sakthikumar Ambady, Raymond L. Page et al. · Cellular Reprogramming Open access 3 Jan 2014 7
24 Phase 1 Clinical Investigation of Human Myeloid Progenitor Cells (CLT-008) As a Supportive Care Measure during Chemotherapy for Acute Myeloid Leukemia (AML) Matthew Joseph Wieduwilt, Jan Černý, Luke Paul Akard et al. · Blood 6 Dec 2014 5
25 Cryopreserved Ex Vivo-Expanded Allogeneic Myeloid Progenitor Cell Product Protects Neutropenic Mice from a Lethal Fungal Infection Jos Domen, Julie L. Christensen, Daphne Gille et al. · Cell Transplantation Open access 2016 5
26 Leader-Independent C-Terminal Modification by a Radical S -Adenosyl- l -methionine Maturase Enables Macrocyclic GLP-1-Like Peptides Jacob Pedigo, Karsten A. S. Eastman, Vahe Bandarian · ACS Bio & Med Chem Au Open access 14 Oct 2025 3
27 Diverse thioether macrocyclized peptides through a radical SAM maturase Karsten A. S. Eastman, Andrew G. Roberts, Vahe Bandarian · Proceedings of the National Academy of Sciences Open access 21 Aug 2025 3
28 Thermal sensitivity of nuclear pore complexes as a potential early driver of heat-induced cell death Natalia Samsonova, Andrey Samsonov · International Journal of Hyperthermia Open access 20 Apr 2026 2
29 Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cells Nicholas Mazzanti, Ninkka Tamot, Andrea Francese et al. · mAbs Open access 11 Dec 2025 2
30 Modeling the Sequence Dependence of Differential Antibody Binding in the Immune Response to Infectious Disease Robayet Chowdhury, Alexander T. Taguchi, Laimonas Kelbauskas et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access Dec 2022 1
31 Tolerance Induction by Myeloid Progenitor Cells Does Not Require Lethal Preconditioning or Hematopoietic Stem Cell Transplantation Y. Li, Anna Sedello, Jos Domen · The Journal of Heart and Lung Transplantation 15 Mar 2019 1
32 Depletion of recipient NK cells significantly increases engraftment of haplo-matched highly purified hematopoietic stem cells Stephanie Smith‐Berdan, Daphne Gille, T. Fong et al. · Transplantation and Cellular Therapy Open access Feb 2006 1
33 Graft protection by myeloid progenitor cells using lethal or non-lethal preconditioning Yongwu Li, Lei Sun, Erica Martinez et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 29 Nov 2025 0
34 Divergent modulation of activated protein C pleiotropic functions by antibodies that differ by a single amino acid Derek Sim, Meenal Shukla, Cornell R Mallari et al. · Blood Advances Open access 29 Oct 2024 0
35 Lead change of a HIF-2α antagonist guided by multiparameter optimization and utilization of an Olp → π*Ar interaction Paul M. Wehn et al. · Research Square PreprintOpen access 10 Apr 2023 0
36 CT-001, a novel next generation factor viia, demonstrates enhanced procoagulant activity in peripartum patient samples Derek S. Sim, Terry W. Hermiston, Terrence K. Allen et al. · American Journal of Obstetrics and Gynecology Open access 2023 0
37 Tolerance Induction by Myeloid Progenitor Cells: Matching Requirements and Expanded Model Y. Li, Anna Sedello, T. Fong et al. · The Journal of Heart and Lung Transplantation 27 Mar 2017 0
38 Ex Vivo Expanded Megakaryocyte Progenitors Generated From Human Mobilized Peripheral Blood CD34+ Stem Cells Can Be Cryopreserved and Transplanted Into NSG Mice to Generate Functional Platelets Holger Karsunky, Robert Tressler, Joy Chananukul · Blood 18 Nov 2011 0
39 Neutropenic Mice Can Be Protected from Fungus Infection by Ex Vivo Expanded Allogeneic Myeloid Progenitors. Jos Domen, Mastura Wahedi, Esther Danenberg et al. · Blood 16 Nov 2005 0
40 Prevention and Reversal of Lupus in NZB/NZW Mice by Transplantation of Purified Allogeneic Hematopoietic Stem Cells (HSC) with Non-Myeloablative Conditioning (NMT). Stephanie Smith‐Berdan, Daphne Gille, Julie L. Christensen · Blood 16 Nov 2006 0
41 Myeloid Progenitors Protect Against Radiation-Induced Intestinal Injury. J. Martin Brown, Sumana Shashidhar, Aida Habtezion et al. · Blood 16 Nov 2005 0
42 84: Prevention and reversal of lupus in NZB/NZW mice by transplantation of purified allogeneic hematopoietic stem cells (HSC) with non-myeloablative conditioning (NMT) Stephanie Smith‐Berdan, Daphne Gille, Julie L. Christensen · Transplantation and Cellular Therapy Open access 26 Jan 2007 0
43 116 Applications of the ΔtBIG method of cooling rate quantification to cell therapy cryopreservation under GMP compliance David L. Frey, Jung Lee · Cryobiology 15 Nov 2013 0
44 Development of a universal and effective myeloid progenitor cell therapeutic for treating neutropenia Julie L. Christensen, Stephanie Smith‐Berdan, Mastura Wahedi et al. · Transplantation and Cellular Therapy Open access Feb 2006 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.